EUVIMEDEUVIMED entdecken
Crossref

Dexamethasone Pretreatment Potentiates a Folic Acid-Functionalized Delivery System for Enhanced Lung Cancer Therapy

Ying Zhao, Changhao Jia, Zhixin Yao, Gang Chen, Gui Huang, Hui Li, Linghong Lu, Taiwei Jin, Yan Tang, Zengyan Zhu, Xuenong Zhang iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.3c00472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Ying Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Children's Hospital of Soochow University, Suzhou 215003, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Jiangsu Provincial Department of Education, National Natural Science Foundation of China, Natural Science Foundation for Higher Education Institutions in Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Folic acid (FA) has been widely engineered to promote the targeted delivery of FA-modified nanoparticles (NPs) by recognizing the folate receptor α (FRα). However, the efficacy of FA-targeted therapy significantly varied with the abundance of FRα and natural immunoglobulin levels in different tumors. Therefore, a sequential therapy of dexamethasone (Dex)-induced FRα amplification and immunosuppression combined with FA-functionalized doxorubicin (DOX) micelles to synergistically suppress tumor proliferation was proposed in this study. In brief, a pH/reduction-responsive FA-functionalized micelle (FCSD) was obtained by grafting FA, derivatization-modified cholesterol, and 2,3-dimethylmaleic anhydride onto a chitosan oligosaccharide. The obtained FCSD/DOX NPs can effectively deliver DOX in tumors, and their targeting efficiency can be further improved with Dex pretreatment to decrease the immunoglobulin M (IgM) content in serum and amplify FRα levels on the surface of M109 cells. After internalization, charge reversal and disulfide bond breakage of FCSD vectors under the stimulation of tumor extracellular pH (pHe) and intracellular glutathione (GSH) would contribute to the disintegration of vectors and the rapid release of DOX. The sequential therapy that combined Dex pretreatment and targeted chemotherapy by FCSD/DOX NPs demonstrated superior tumor suppression compared with monotherapy, which is expected to provide a potential strategy for FRα-positive lung cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsNanoparticlesHumansDrug CarriersFolic AcidDoxorubicinMicellesDexamethasoneDrug Delivery SystemsHydrogen-Ion Concentration

Stichwörter der Autor:innen

FA-targeted delivery systemFRα upregulationdexamethasonenatural immunoglobulinsequential therapy

Substanzen

Drug CarriersFolic AcidDoxorubicinMicellesDexamethasone

Autor:innen und Institutionen

  • Department of Pharmacy, Children's Hospital of Soochow University, Suzhou 215003, China.
  • Department of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.
  • School of Pharmacy, Yancheng Teachers' University, Yancheng 224002, China.
  • Children's Hospital of Wujiang District, Suzhou 215200, China.

ORCID-Profile: Xuenong Zhang

Förderung

  • Jiangsu Provincial Department of Education
  • National Natural Science Foundation of China
  • Natural Science Foundation for Higher Education Institutions in Jiangsu Province

Zitieren

APA

Zhao, Y., Jia, C., Yao, Z., Chen, G., Huang, G., Li, H., Lu, L., Jin, T., Tang, Y., Zhu, Z., & Zhang, X. (2024). Dexamethasone Pretreatment Potentiates a Folic Acid-Functionalized Delivery System for Enhanced Lung Cancer Therapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00472

Vancouver

Zhao Y, Jia C, Yao Z, Chen G, Huang G, Li H, et al. Dexamethasone Pretreatment Potentiates a Folic Acid-Functionalized Delivery System for Enhanced Lung Cancer Therapy. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c00472

BibTeX
@article{Zhao2024,
  author = {Zhao, Ying and Jia, Changhao and Yao, Zhixin and Chen, Gang and Huang, Gui and Li, Hui and Lu, Linghong and Jin, Taiwei and Tang, Yan and Zhu, Zengyan and Zhang, Xuenong},
  title = {Dexamethasone Pretreatment Potentiates a Folic Acid-Functionalized Delivery System for Enhanced Lung Cancer Therapy},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.3c00472}
}
Kostenlos starten →